KRTL Holding Group, Inc. manufactures and distributes water. The company is headquartered in Lakewood, Colorado. The company went IPO on 2001-06-21. The firm operates through its subsidiaries, including KRTL Biotech, Inc., KRTL International Corp and Neurogen Brain Balancing, LLC (Neurogen). KRTL Biotech, Inc. is a pharmaceutical company focused on the commercialization of APIs and licensing agreements within the pharmaceutical and nutraceutical sectors. KRTL Biotech, Inc. focuses on biotechnology, particularly in securing and developing global partnerships for the sourcing and distribution of critical APIs and wellness-focused compounds. KRTL International Corp focuses on bridging global markets through international consulting, trade and distribution of advanced bio and agri-technologies and services. Neurogen is a neurotechnology company focused on advanced brain balancing therapies and personalized cognitive optimization systems.
KRTL stock price ended at $0.06 on 星期四, after rising 0.00%
On the latest trading day Feb 12, 2026, the stock price of KRTL rose by 0.00%, climbing from $0.06 to $0.06. During the session, the stock saw a volatility of 20.00%, with prices oscillating between a daily low of $0.05 and a high of $0.06. Notably, trading volume dropped by 2.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 7.7K shares were traded, equating to a market value of approximately $4.4M.